Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.04
INFU's Cash to Debt is ranked lower than
53% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.33 vs. INFU: 0.04 )
INFU' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.04

Equity to Asset 0.57
INFU's Equity to Asset is ranked higher than
69% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. INFU: 0.57 )
INFU' s 10-Year Equity to Asset Range
Min: 0.51   Max: 0.73
Current: 0.57

0.51
0.73
Interest Coverage 1.69
INFU's Interest Coverage is ranked lower than
51% of the 208 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.54 vs. INFU: 1.69 )
INFU' s 10-Year Interest Coverage Range
Min: 0.6   Max: 9999.99
Current: 1.69

0.6
9999.99
F-Score: 7
Z-Score: 1.73
M-Score: -2.55
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 12.77
INFU's Operating margin (%) is ranked higher than
81% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.78 vs. INFU: 12.77 )
INFU' s 10-Year Operating margin (%) Range
Min: -121.45   Max: 13.67
Current: 12.77

-121.45
13.67
Net-margin (%) 4.48
INFU's Net-margin (%) is ranked higher than
73% of the 306 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.09 vs. INFU: 4.48 )
INFU' s 10-Year Net-margin (%) Range
Min: -83.17   Max: 28.12
Current: 4.48

-83.17
28.12
ROE (%) 7.00
INFU's ROE (%) is ranked higher than
73% of the 304 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.62 vs. INFU: 7.00 )
INFU' s 10-Year ROE (%) Range
Min: -72.53   Max: 13.38
Current: 7

-72.53
13.38
ROA (%) 3.87
INFU's ROA (%) is ranked higher than
74% of the 311 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. INFU: 3.87 )
INFU' s 10-Year ROA (%) Range
Min: -43.99   Max: 8.56
Current: 3.87

-43.99
8.56
ROC (Joel Greenblatt) (%) 35.29
INFU's ROC (Joel Greenblatt) (%) is ranked higher than
86% of the 310 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.33 vs. INFU: 35.29 )
INFU' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -318.97   Max: 40.32
Current: 35.29

-318.97
40.32
Revenue Growth (%) 5.70
INFU's Revenue Growth (%) is ranked higher than
75% of the 279 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.70 vs. INFU: 5.70 )
INFU' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 87.9
Current: 5.7

0
87.9
EBITDA Growth (%) 18.00
INFU's EBITDA Growth (%) is ranked higher than
87% of the 234 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. INFU: 18.00 )
INFU' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 18
Current: 18

0
18
» INFU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

INFU Guru Trades in Q3 2013

Whitney Tilson 10,000 sh (New)
» More
Q4 2013

INFU Guru Trades in Q4 2013

Whitney Tilson Sold Out
» More
Q1 2014

INFU Guru Trades in Q1 2014

Mario Gabelli 28,980 sh (New)
» More
Q2 2014

INFU Guru Trades in Q2 2014

Mario Gabelli 28,980 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with INFU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2014-03-31 New Buy$2.12 - $2.98 $ 3.1523%28980
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 22.70
INFU's P/E(ttm) is ranked higher than
88% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.90 vs. INFU: 22.70 )
INFU' s 10-Year P/E(ttm) Range
Min: 2.73   Max: 98.44
Current: 22.7

2.73
98.44
P/B 1.60
INFU's P/B is ranked higher than
88% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.90 vs. INFU: 1.60 )
INFU' s 10-Year P/B Range
Min: 0.33   Max: 1.6
Current: 1.6

0.33
1.6
P/S 1.10
INFU's P/S is ranked higher than
91% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. INFU: 1.10 )
INFU' s 10-Year P/S Range
Min: 0.36   Max: 6.18
Current: 1.1

0.36
6.18
EV-to-EBIT 11.16
INFU's EV-to-EBIT is ranked higher than
93% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.54 vs. INFU: 11.16 )
INFU' s 10-Year EV-to-EBIT Range
Min: 10   Max: 200.6
Current: 11.16

10
200.6
Current Ratio 1.55
INFU's Current Ratio is ranked higher than
57% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.81 vs. INFU: 1.55 )
INFU' s 10-Year Current Ratio Range
Min: 0.01   Max: 483.08
Current: 1.55

0.01
483.08
Quick Ratio 1.41
INFU's Quick Ratio is ranked higher than
65% of the 305 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. INFU: 1.41 )
INFU' s 10-Year Quick Ratio Range
Min: 0.01   Max: 483.08
Current: 1.41

0.01
483.08

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.50
INFU's Price/Tangible Book is ranked higher than
81% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.41 vs. INFU: 3.50 )
INFU' s 10-Year Price/Tangible Book Range
Min: 1.07   Max: 10.29
Current: 3.5

1.07
10.29
Price/DCF (Projected) 1.20
INFU's Price/DCF (Projected) is ranked higher than
93% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.35 vs. INFU: 1.20 )
INFU' s 10-Year Price/DCF (Projected) Range
Min: 0.27   Max: 1.07
Current: 1.2

0.27
1.07
Price/Median PS Value 1.10
INFU's Price/Median PS Value is ranked higher than
77% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. INFU: 1.10 )
INFU' s 10-Year Price/Median PS Value Range
Min: 0.38   Max: 5.03
Current: 1.1

0.38
5.03
Price/Graham Number 1.90
INFU's Price/Graham Number is ranked higher than
88% of the 323 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.99 vs. INFU: 1.90 )
INFU' s 10-Year Price/Graham Number Range
Min: 0.87   Max: 2.61
Current: 1.9

0.87
2.61
Earnings Yield (Greenblatt) 9.00
INFU's Earnings Yield (Greenblatt) is ranked higher than
89% of the 264 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. INFU: 9.00 )
INFU' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.5   Max: 10
Current: 9

0.5
10
Forward Rate of Return (Yacktman) 3.30
INFU's Forward Rate of Return (Yacktman) is ranked higher than
76% of the 266 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.14 vs. INFU: 3.30 )
INFU' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.9   Max: 20.6
Current: 3.3

3.9
20.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Infusystem Holdings, Inc. is a provider of ambulatory infusion pumps and related services in the United States. It provides services to hospitals, oncology practices and facilities and other alternate site health care providers.
» More Articles for INFU

Headlines

Articles On GuruFocus.com
Applying Buffett’s Arbitrage Techniques to Infusystem Jul 31 2013 
InfuSystem Buyout Coming with 32% Upside Potential Jul 22 2013 
comment on INFU May 14 2013 
comment on INFU Apr 15 2013 
comment on INFU Jan 13 2013 
comment on INFU Jan 08 2013 
comment on INFU Jan 02 2013 

More From Other Websites
INFUSYSTEM HOLDINGS, INC Financials Aug 08 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 01 2014
InfuSystem Holdings, Inc. Reports Second Quarter Revenue of $16.4 Million and Net Profit of $0.04... Aug 01 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 10 2014
InfuSystem Holdings, Inc. to Issue Second Quarter 2014 Financial Results on Friday, August 1, 2014 Jul 09 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Change in Directors or Principal Officers Jul 09 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... May 28 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... May 20 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... May 16 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 12 2014
InfuSystem Holdings, Inc. Announces Results of 2014 Annual Meeting of Stockholders May 09 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 08 2014
InfuSystem's (INFU) CEO Eric Steen On Q1 2014 Results - Earnings Call Transcript May 05 2014
InfuSystem Holdings, Inc. Reports First Quarter Revenue of $17.2 Million and Net Profit of $0.03 per... May 05 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2014
Jewett-Cameron Trading Company: Jewel Among Other Nano Cap Stones May 02 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Results of Operations and Financial Condition,... Apr 28 2014
InfuSystem Holdings, Inc. to Issue First Quarter 2014 Financial Results on Monday, May 5, 2014 Apr 28 2014
ISS Recommends a Vote "FOR" All Infusystem Holdings, Inc. Annual Meeting Agenda Items Apr 24 2014
INFUSYSTEM HOLDINGS, INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 23 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK